Jacob E Tallman

11PUBLICATIONS
53CO-AUTHORS
Molecular targetsRehabilitation engineeringRadiation therapyMedical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 26, 2026
Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.

|Mar 20, 2026
Management of Intravesical Therapy-Related Lower Urinary Tract Symptoms-Leveraging Existing Options to Improve Outcomes.

Jacob E Tallman, Parth Modi, Sarah Faris

|May 28, 2025
Reply: Perioperative Complications and Omission of Ureteral Stents During Robot-Assisted Radical Cystectomy With Intracorporeal Ileal Conduit.

Jacob E Tallman, Alvin C Goh

|Apr 04, 2025
Toward Improved Prostate Cancer Screening: Insights from the Göteborg-2 Trial.

Jacob E Tallman, Sigrid V Carlsson, Hans Lilja

|May 01, 2024
Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer.

Andrew T Lenis, Karissa Whiting, Vignesh Ravichandran

|Mar 14, 2023
Correction to: Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer.

Jacob E Tallman, Christopher J D Wallis, Li-Ching Huang

Pageof 2

Frequent Collaborators

4 joint publications

Christopher J D Wallis

4 joint publications

David F Penson

2 joint publications

Ann S Hamilton

2 joint publications

Lisa E Paddock